SPRO - スマ―トプロス (Spero Therapeutics Inc.)

SPROのニュース

   Spero Therapeutics antibiotic SPR206 shows promise in phase 1 trial  2022/02/16 14:06:09 Seeking Alpha
Spero Therapeutics (SPRO) reported positive results from a phase 1 trial of its antibiotic SPR206 to treat serious multi-drug resistant ((MDR)) gram-negative infections in the…
   Spero Therapeutics Sees Positive Topline Results for Antibiotic Trial  2022/02/16 13:17:00 MarketWatch
By Chris Wack Spero Therapeutics Inc. said it saw positive topline findings from its Phase 1 bronchoalveolar lavage clinical trial of SPR206, an…
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []

calendar